Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary Syndromes
Top Cited Papers
- 9 March 2007
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 49 (12) , 1362-1368
- https://doi.org/10.1016/j.jacc.2007.02.027
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Bivalirudin for Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2006
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCirculation, 2006
- A Comparison of the Clinical Impact of Bleeding Measured by Two Different Classifications Among Patients With Acute Coronary SyndromesJournal of the American College of Cardiology, 2006
- Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting StentsJAMA, 2005
- Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary SyndromesJAMA, 2004
- Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)European Heart Journal, 2003
- Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary InterventionJAMA, 2003
- Contemporary Evaluation and Management of Hypertrophic CardiomyopathyCirculation, 2002
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998